Two strategies may enhance breast cancer treatment.
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000235:genetics / Q000628:therapy*; D000077143:Docetaxel; D005260:Female; D005820:Genetic Testing; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel